In June I will be swapping my busy schedule of client CARA Life Science implementations for an equally hectic and rewarding life...

The visible operational impact of our CARA platform is driving impressive and accelerating growth across regulated industries,...

It’s with a great sense of promise and excitement that I have begun my new role with Generis as Head of Life Sciences. It’s very clear...

If 2020 was a bumper year for Generis, then 2021 was stronger still. Revenues rose by more than 30% and we grew our workforce by over...

Medical device manufacturers have long been the neglected cousins of pharma companies in terms of IT systems that specifically cater to...

Digital transformation goals and software support needs are likely to differ If there’s one thing medical device manufacturers want...

Guest blog by Torsten Friedel & Djenan Ganic, Directors at Intilaris LifeSciences In the digital era there is no place for departmental...

Guest blog by Lisa Cooney, Director, Operations Transformation - Life Sciences, Grant Thornton LLP If there’s one issue that unites all...

-Faster, easier, eminently flexible and with a heritage unmatched by its content management rivals- Pharmaceutical information-based...

Without really understanding how or why, enterprise customers are convinced that they must specify an AI capability in just about any...

In a cloud-first, try-before-you-buy digital era, businesses should be very sceptical about allocating budget to software vendors that...

The life sciences industry may have been slower than other markets to appreciate the benefits of holistic data and document management,...

Given the choice of buying a “tool,” a “solution” or a “platform,” businesses are opting increasingly for the last of these, believing...

We’ve been canvassing their views about what this means to them and the value this brings to the company. Was it a conscious decision to...